• Publications
  • Influence
Tularemia as a biological weapon: medical and public health management.
OBJECTIVE The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals if tularemia is used as aExpand
Botulinum toxin as a biological weapon: medical and public health management.
People potentially exposed to botulinum toxin should be closely observed, and those with signs of botulism require prompt treatment with antitoxin and supportive care that may include assisted ventilation for weeks or months. Expand
Anthrax as a biological weapon, 2002: updated recommendations for management.
This revised consensus statement presents new information based on the analysis of the anthrax attacks of 2001, including developments in the investigation of the Anthrax Attacks of 2001; important symptoms, signs, and laboratory studies; new diagnostic clues that may help future recognition of this disease; updated antibiotic therapeutic considerations; and judgments about environmental surveillance and decontamination. Expand
Practice guidelines for the management of infectious diarrhea.
Prevention by avoidance of undercooked meat or seafood, avoidance of unpasteurized milk or soft cheese, and selected use of available typhoid vaccines for travelers to areas where typhoid is endemic are key to the control of infectious diarrhea. Expand
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Specific recommendations are made regarding smallpox vaccination, therapy, postexposure isolation and infection control, hospital epidemiology and infection Control, home care, decontamination of the environment, and additional research needs. Expand
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
The final statement incorporates all relevant evidence obtained by the literature search in conjunction with final consensus recommendations supported by all working group members. Expand
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.
Influenza vaccines can provide moderate protection against virologically confirmed influenza, but such protection is greatly reduced or absent in some seasons. Expand
Preparing for the next pandemic.
The 1918-19 pandemic killed 50 to 100 million people globally, and with a population of 6.5 billion, more than three times that of 1918, even a "mild" pandemic could kill many millions of people. Expand
Hemorrhagic fever viruses as biological weapons: medical and public health management.
Weapons disseminating a number of HFVs could cause an outbreak of an undifferentiated febrile illness 2 to 21 days later, associated with clinical manifestations that could include rash, hemorrhagic diathesis, and shock. Expand
[Preparing for the next pandemic].
The fragile and limited production capacity of our 1950s egg-based technology for producing influenza vaccine and the lack of a national commitment to universal annual influenza vaccination mean thatExpand